Irina Antonijevic - 11 May 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd.

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
11 May 2022
Net transactions value
$0
Form type
4
Filing time
12 May 2022, 20:57:58 UTC
Previous filing
11 May 2022
Next filing
30 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Restricted Share Unit Award Award $0 +5,070 $0.000000 5,070 11 May 2022 Common Shares 5,070 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents the contingent right to receive one common share of the issuer.
F2 The reporting person was granted 5,070 restricted share units on May 11, 2022, vesting in four equal installments on May 11, 2022, 2023, 2024 and 2025 subject to the reporting person's continued service with the issuer at each vesting date.
F3 Not applicable.